How much funding has Sage Therapeutics raised?

Sage Therapeutics has raised $35.0M in total funding, most recently a Series A round.

When was Sage Therapeutics founded?

Sage Therapeutics was founded in 2010.

Where is Sage Therapeutics headquartered?

Sage Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Sage Therapeutics in?

Sage Therapeutics operates in Biotech, Healthcare.

How many employees does Sage Therapeutics have?

Sage Therapeutics has 201-500 employees.

Sage Therapeutics

Pioneering life-changing brain health medicines.

Cambridge, United States · Founded 2010 · $35.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2010
Business Model: B2B

Website: sagerx.com
Total Funding: $35.0M
Last Round: $35.0M Series AOct 2011
Rounds: 1

About

Sage Therapeutics is a biopharmaceutical company pioneering novel CNS therapies for brain health conditions. Known for FDA-approved Zurzuvae (zuranolone) for postpartum depression, Sage develops medicines targeting GABA and NMDA receptor systems to transform treatment of depression and other neurological disorders. Acquired by Supernus Pharmaceuticals.

Summary

Sage Therapeutics is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Oct 2011.

LinkedIn X (Twitter)